Kits Eyecare Ltd. Announces Closing of Secondary Offering of Common Shares

In This Article:

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/

VANCOUVER, BC, Sept. 26, 2024 /CNW/ - Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, is pleased to announce the closing of the previously announced secondary offering of common shares of the Company (the "Common Shares") pursuant to which Canaccord Genuity Corp., as sole bookrunner and co-lead underwriter, together with Beacon Securities Limited, as co-lead underwriter, on behalf of a syndicate of underwriters (collectively, the "Underwriters") purchased, on a bought deal basis, an aggregate of 1,125,000 Common Shares held by Roger Hardy and entities managed by Roger Hardy (the "Hardy Shareholders"), LD Group Holdings Ltd. ("LD Group") and Joseph Thompson (together with the Hardy Shareholders and LD Group, the "Selling Securityholders") at an offering price of $10.15 per share (the "Offering Price") for total gross proceeds to the Selling Securityholders of $11,418,750 (the "Offering"). KITS did not receive any proceeds from the Offering.

Kits Eyecare Ltd. Logo (CNW Group/KITS Eyecare Ltd.)
Kits Eyecare Ltd. Logo (CNW Group/KITS Eyecare Ltd.)

Prior to the Offering, Roger Hardy, directly or indirectly, owned or controlled an aggregate of 10,077,860 Common Shares, representing approximately 31.93% of the issued and outstanding Common Shares. Immediately following the closing of the Offering, Roger Hardy, directly or indirectly, owns or controls an aggregate of 9,152,860 Common Shares, representing approximately 29.0% of the issued and outstanding Common Shares; the LD Group, directly or indirectly, owns or controls 10,520,589 Common Shares, representing approximately 33.3% of the issued and outstanding Common Shares; and Joseph Thompson, directly or indirectly, owns or controls 224,329 Common Shares, representing approximately 0.7% of the issued and outstanding Common Shares.

As previously announced, the Underwriters have been granted an over-allotment option (the "Over-Allotment Option") to purchase up to an additional 168,750 Common Shares from the Selling Securityholders at the Offering Price for additional gross proceeds of $1,712,812.50 if the Over-Allotment Option is exercised in full. The Over-Allotment Option can be exercised at any time, in whole or in part, for a period of 30 days from the closing date of the Offering.

The Company also announces that, concurrently with the closing of the Offering, in a previously announced transaction, the Underwriters have closed their purchase on a bought deal basis from the spouse of Sabrina Liak, 325,000 Common Shares at the Offering Price for total gross proceeds of $3,298,750 (the "Concurrent Block Trade"). Immediately following the closing of the Concurrent Block Trade, Sabrina Liak and her spouse, directly or indirectly, own or control 3,540,089 Common Shares, representing approximately 11.2% of the issued and outstanding Common Shares.